Protalix BioTherapeutics Reports Second Quarter 2022 Financial and Business Results

Go back to Protalix BioTherapeutics Reports Second Quarter 2022 Financial and Business Results
POWERSHARES GLOBAL CLEAN ENERGY PORTFOLIO (NYSE: PBD) Delayed: 19.62 -0.82 (4.01%)
Previous Close $20.44    52 Week High $11.63 
Open $19.67    52 Week Low $9.19 
Day High $19.80    P/E N/A 
Day Low $19.47    EPS $0.00 
Volume 26,493       

POWERSHARES GLOBAL CLEAN ENERGY PORTFOLIO (NYSE: PBD) Delayed: 19.62 -0.82 (4.01%)
Previous Close $20.44    52 Week High $11.63 
Open $19.67    52 Week Low $9.19 
Day High $19.80    P/E N/A 
Day Low $19.47    EPS $0.00 
Volume 26,493       

PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.18 +0.02 (0.93%)
Previous Close $2.16    52 Week High $1.11 
Open $2.15    52 Week Low $0.41 
Day High $2.23    P/E N/A 
Day Low $2.13    EPS $-0.29 
Volume 209,381       

PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.18 +0.02 (0.93%)
Previous Close $2.16    52 Week High $1.11 
Open $2.15    52 Week Low $0.41 
Day High $2.23    P/E N/A 
Day Low $2.13    EPS $-0.29 
Volume 209,381